Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Extended Virulence Genotypes ofEscherichia coliStrains from Patients with Urosepsis in Relation to Phylogeny and Host Compromise
2000 Standout
Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection
2006
Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans
1994
Impact of the HIV epidemic on trends in tuberculosis in Abidjan, Côte d'Ivoire
1995
Bacteremia in Malawian Children with Severe Malaria: Prevalence, Etiology, HIV Coinfection, and Outcome
2007
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial
2007 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Syndemics and the biosocial conception of health
2017 Standout
A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus
1997
Increased Risk for Severe Malaria in HIV-1–infected Adults, Zambia
2009
A Prospective Study of Community-Acquired Bloodstream Infections Among Febrile Adults Admitted to Mulago Hospital in Kampala, Uganda
1998
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
2009 Standout
Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients
2000
Genomic Characterisation of Invasive Non-Typhoidal Salmonella enterica Subspecies enterica Serovar Bovismorbificans Isolates from Malawi
2013
Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire
1995
The Diagnosis of Prosthetic Joint Infection
2005
Research issues involving HIV-associated tuberculosis in resource-poor countries
1996
Tuberculosis
2011
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease
2007
Pneumocystis carinii Pneumonia: An Uncommon Cause of Death in African Patients with Acquired Immunodeficiency Syndrome
1992
Clinical management of tuberculosis and HIV-1 co-infection
2010
Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials
1999
Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial
1999
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
2007 Standout
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba hospital, Malawi
1998
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Unrecognised Mycobacterium tuberculosis bacteraemia among hospital inpatients in less developed countries
1999
Melioidosis
2012 Standout
Pulmonary Tuberculosis in HIV-Infected Patients in Zaire — A Controlled Trial of Treatment for Either 6 or 12 Months
1995
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
HIV and malaria: A lesson in immunology?
1992
Development of Vaccines Against Burkholderia Pseudomallei
2011
Antimicrobial resistance in developing countries. Part I: recent trends and current status
2005
Epidemiologic Changes in Bacteremic Pneumococcal Disease in Patients With Human Immunodeficiency Virus in the Era of Highly Active Antiretroviral Therapy
2005
Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results
1992
HIV infection in Haiti: natural history and disease progression
2000
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Comparison of Molecular Methods for Subtyping Patients and Epidemiologically Linked Environmental Isolates of Legionella pneumophila
1988
Global Burden of Tuberculosis
1999 Standout
Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study
2007
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
2014 Standout
Malaria
2013 Standout
Morbidity and Mortality in South African Gold Miners: Impact of Untreated Disease Due to Human Immunodeficiency Virus
2002
Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis
1991
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
1996
Prosthetic joint infection development of an evidence-based diagnostic algorithm
2017
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
2010
Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut
2008
Influence of microbial infections on the progression of HIV disease
1997 StandoutNobel
Autopsy Study of HIV-1–Positive and H IV-1–Negative Adult Medical Patients in Nairobi, Kenya
2000
The Mycobacterium tuberculosis Virulence Factor Trehalose Dimycolate Imparts Desiccation Resistance to Model Mycobacterial Membranes
2008 StandoutNobel
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
1994
23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial
2000
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Nasopharyngeal carriage ofStaphylococcus aureus and carriage of tetracycline-resistant strains associated with HIV-seropositivity
1995
Quantitative Bacillary Response to Treatment in HIV-associated Pulmonary Tuberculosis
1993
Male circumcision for prevention of heterosexual acquisition of HIV in men
2003
HIV‐associated lymphoma in Africa: An autopsy study in Ĉote D'ivoire
1994
Fever and Human Immunodeficiency Virus Infection as Sentinels for Emerging Mycobacterial and Fungal Bloodstream Infections in Hospitalized Patients ⩾15 Years Old, Bangkok
1999
Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial
2005 Standout
Functional Specialization of Interleukin-17 Family Members
2011 Standout
The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia
1995
Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis
2000 Standout
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
HIV and male circumcision—a systematic review with assessment of the quality of studies
2005
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial
2006
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
A Hospital‐Based Prevalence Survey of Bloodstream Infections in Febrile Patients in Malawi: Implications for Diagnosis and Therapy
2000
Changing Clinical Presentation and Survival in HIV-Associated Tuberculosis After Highly Active Antiretroviral Therapy
2001
The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease
2018 Standout
Bacteraemia and Mortality Among Adult Medical Admissions in Malawi – Predominance of Non-typhi Salmonellae andStreptococcus pneumoniae
2001
Accelerated course of human immunodeficiency virus infection after tuberculosis.
1995
The clinical challenge of the HIV epidemic in the developing world
1993
A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis
1995
Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi
1999
Opportunities and Challenges for HIV Care in Overlapping HIV and TB Epidemics
2008
Corticosteroids for Bacterial Meningitis in Adults in Sub-Saharan Africa
2007
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes
2007
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
2010 Standout
FatalMycobacterium tuberculosisBloodstream Infections in Febrile Hospitalized Adults in Dar es Salaam, Tanzania
1998
Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis
1997
Pathogens and Predictors of Fatal Septicemia Associated with Human Immunodeficiency Virus Infection in Ivory Coast, West Africa
1993
Maternal mortality: who, when, where, and why
2006 Standout
The Growing Burden of Tuberculosis
2003 Standout
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
2002
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Human Immunodeficiency Virus and the Outcome of Treatment for New and Recurrent Pulmonary Tuberculosis in African Patients
1999
A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death.
1999
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
1993 Standout
HIV-associated tuberculosis in developing countries: clinical features, diagnosis, and treatment.
1992
The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation.
1996 StandoutNobel
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Elevated serum concentrations of soluble CD14 in HIV− and HIV+ patients with tuberculosis in Africa: prolonged elevation during anti-tuberculosis treatment
2000
Rv2131c fromMycobacterium tuberculosisIs a CysQ 3′-Phosphoadenosine-5′-phosphatase
2008 StandoutNobel
Clonal relationships among bloodstream isolates of Escherichia coli
1995
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults
1993 Standout
Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins
2014 Standout
Diagnosing Fracture-Related Infection: Current Concepts and Recommendations
2019
Development of a standardized subgrouping scheme for Legionella pneumophila serogroup 1 using monoclonal antibodies
1986
Immunogold and fluorescein immunolabelling of Legionella pneumophila within an aquatic biofilm visualized by using episcopic differential interference contrast microscopy
1992
Legionella and Legionnaires' Disease: 25 Years of Investigation
2002 Standout
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
2001
The Immune Response in Tuberculosis
2013 Standout
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
1997 Standout
Male circumcision for prevention of heterosexual acquisition of HIV in men
2009 Standout
Subtyping of Legionella pneumophila serogroup 1 isolates by monoclonal antibody and plasmid techniques
1987
Musculoskeletal Infection in Pediatrics
2019
Musculoskeletal Infection in Orthopaedic Trauma
2020
Prosthetic Joint Infection
2014 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults
2007
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Changing Clinical Presentation and Survival in HIV-Associated Tuberculosis After Highly Active Antiretroviral Therapy
2001
Works of Robert Newnham being referenced
Infection and morbidity in patients with tuberculosis in Nairobi, Kenya
1993
Use of an automated blood culture system (BD BACTEC™) for diagnosis of prosthetic joint infections: easy and fast
2014
Cohort Study of Human Immunodeficiency Virus Infection in Patients with Tuberculosis in Nairobi, Kenya: Analysis of Early (6-Month) Mortality
1992
Microbiological diagnosis of prosthetic joint infections: a prospective evaluation of four bacterial culture media in the routine laboratory
2011
Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya
1996
Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi
1990
The Presentation and Outcome of HIV-related Disease in Nairobi
1992
Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya
1990
Sonication versus Tissue Sampling for Diagnosis of Prosthetic Joint and Other Orthopedic Device-Related Infections
2018
Legionella pneumophilaserogroup 1 subgrouping by monoclonal antibodies – an epidemiological tool
1985